Categories AlphaGraphs, Earnings, Retail

Macy’s stock rises on strong Q1 earnings

Macy’s (NYSE: M) reported first-quarter 2021 financial results before the regular market hours on Tuesday. The department store chain reported Q1 revenue of $4.71 billion, up 56% year-over-year and above the Wall Street projection. Meanwhile, the company reported net earnings of $0.39 per share, even as the street was expecting a loss.

M shares rose 4.9% immediately following the announcement. The stock has risen 71% since the beginning of this year.

Macy's Q1 2021 earnings

Looking forward to listening to management / analyst comments on the results? Stay tuned here for Macy’s Q1 earnings call transcript

CEO Jeff Gennette said, “With a healthier economy and the reopening of communities as the backdrop to the execution of our Polaris strategy, we are well positioned to deliver sustainable, profitable growth in 2021 and the years beyond.”

Prior performance

  • Macy's reports Q3 2020 earnings results
  • Macy's Q2 2020 earnings infographic.
  • Macy's (M) Q1 2020 Earnings Infograph

Most Popular

Infographic: Highlights of DocuSign’s (DOCU) Q1 2024 results

DocuSign, Inc. (NASDAQ: DOCU), a leading provider of electronic signature solutions, Thursday reported first-quarter earnings. It also provided guidance for the second quarter and fiscal 2024. The company's top line

Macy’s (M): A few points to consider if you have an eye on this retailer

Shares of Macy’s, Inc. (NYSE: M) stayed in red on Thursday. The stock has dropped 22% year-to-date and 32% over the past 12 months. The retailer witnessed sales and profit

Ocean Biomedical’s scientific co-founder Dr. Jonathan Kurtis gets new patent for malaria vaccine

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharmaceutical company focused on clinical programs in oncology, fibrosis, and infectious disease, Thursday said its scientific co-founder Dr. Jonathan Kurtis received a new patent

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top